Just diagnosed with Juvenile myasthenia gravis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Juvenile myasthenia gravis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Juvenile myasthenia gravis hub →Overview
Juvenile myasthenia gravis is a rare condition. Also known as Childhood myasthenia gravis, Juvenile acquired myasthenia, Juvenile autoimmune myasthenia gravis. Tomeko brings together the specialists, research, clinical trials, treatments and community for Juvenile myasthenia gravis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:391497 · ICD-10 G70.0 · GARD 0021624
Find care for Juvenile myasthenia gravis
Authoritative references for Juvenile myasthenia gravis
Research & market landscape for Juvenile myasthenia gravis
Following Juvenile myasthenia gravis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Juvenile myasthenia gravis — the real-world landscape behind the condition, in one place.
- Latest Juvenile myasthenia gravis research on PubMed ↗
- Recruiting Juvenile myasthenia gravis trials on ClinicalTrials.gov ↗
- Explore the Juvenile myasthenia gravis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Juvenile myasthenia gravis and every rare condition. See how Tomeko works with industry →
Common questions
What is Juvenile myasthenia gravis?
Juvenile myasthenia gravis is a rare condition. Also known as Childhood myasthenia gravis, Juvenile acquired myasthenia, Juvenile autoimmune myasthenia gravis. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Juvenile myasthenia gravis together in one place.
What are the symptoms of Juvenile myasthenia gravis?
Symptoms of Juvenile myasthenia gravis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Juvenile myasthenia gravis.
How is Juvenile myasthenia gravis treated?
Treatment for Juvenile myasthenia gravis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Juvenile myasthenia gravis, and review current options with them.
What causes Juvenile myasthenia gravis — is it genetic?
The cause and inheritance of Juvenile myasthenia gravis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Juvenile myasthenia gravis can explain what it means for you and your family.
I was just diagnosed with Juvenile myasthenia gravis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Juvenile myasthenia gravis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Juvenile myasthenia gravis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Juvenile myasthenia gravis, filtered to your area.
Are there clinical trials for Juvenile myasthenia gravis?
Tomeko shows live, recruiting studies for Juvenile myasthenia gravis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion
